Improvement of redness and hyperkeratosis in a case of Nagashima-type palmoplantar keratosis during Tofacitinib treatment for ulcerative colitis

J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e797-e798. doi: 10.1111/jdv.18276. Epub 2022 Jun 7.

Authors

C Shiiya¹, N Ono¹, S Aoki¹, M Amagai¹, A Kubo^{1

2}

Affiliations

¹ Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
² Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan.

PMID: 35620940
DOI: 10.1111/jdv.18276

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Colitis, Ulcerative* / drug therapy
Humans
Keratoderma, Palmoplantar* / chemically induced
Keratoderma, Palmoplantar* / drug therapy
Piperidines / adverse effects
Pyrimidines / adverse effects

Substances

Piperidines
Pyrimidines
tofacitinib

Grants and funding